Page 23
Title: Peritoneal Carcinomatosis: Role of 18F-FDG PET
Autohors: Turlakow, Alla; Yeung, Henry W.; Salmon, Aida Sanchez; Macapinlac,
Homer A.; Larson, Steven M.
Date: 09/01/2003
Volume: 44
Issue: 9
Abstract | Full
Text
Title: Peroperative frozen section analysis of TTF-1 antigen expression
Autohors: Camilleri-Broet, S; Alifano, M; Morcos, M; Comperat, E; Magdeleinat,
P; Marmey, B; Molina, T J; Regnard, J-F; Audouin, J
Date: 01/01/2004
Volume: 57
Issue: 1
Abstract | Full
Text
Title: Peroxiredoxins in Breast Carcinoma
Autohors: Karihtala, Peeter; Mantyniemi, Anne; Kang, Sang Won; Kinnula,
Vuokko L.; Soini, Ylermi
Date: 08/01/2003
Volume: 9
Issue: 9
Abstract | Full
Text
Title: PET Evaluation of Lung Cancer
Autohors: Bunyaviroch, Tira; Coleman, R. Edward
Date: 03/01/2006
Volume: 47
Issue: 3
Abstract | Full
Text
Title: Phase I and Pharmacokinetic Study of Ecteinascidin 743 Administered
as a 72-Hour Continuous Intravenous Infusion in Patients with Solid Malignancies
Autohors: Ryan, David P.; Supko, Jeffrey G.; Eder, J. Paul; Seiden, Michael
V.; Demetri, George; Lynch, Thomas J.; Fischman, Alan J.; Davis, John; Jimeno,
Jose; Clark, Jeffrey W.
Date: 02/01/2001
Volume: 7
Issue: 2
Abstract | Full
Text
Title: Phase I and Pharmacokinetic Study of Irofulven Administered
Weekly or Biweekly in Advanced Solid Tumor Patients
Autohors: Alexandre, Jerome; Raymond, Eric; Kaci, Mahmoud Ould; Brain,
Etienne C.; Lokiec, Francois; Kahatt, Carmen; Faivre, Sandrine; Yovine, Alejandro;
Goldwasser, Francois; Smith, Sheri L.; MacDonald, John R.; Misset, Jean-Louis;
Cvitkovic, Esteban
Date: 05/15/2004
Volume: 10
Issue: 10
Abstract | Full
Text
Title: Phase I and Pharmacokinetic Study of Prinomastat, a Matrix Metalloprotease
Inhibitor
Autohors: Hande, Kenneth R.; Collier, Mary; Paradiso, Linda; Stuart-Smith,
Jill; Dixon, Mary; Clendeninn, Neil; Yeun, Geoff; Alberti, Donna; Binger, Kim;
Wilding, George
Date: 02/01/2004
Volume: 10
Issue: 3
Abstract | Full
Text
Title: Phase I and pharmacokinetic study of the multitargeted antifolate
pemetrexed in combination with oxaliplatin in patients with advanced solid tumors
Autohors: Misset, J. L.; Gamelin, E.; Campone, M.; Delaloge, S.; Latz,
J. E.; Bozec, L.; Fumoleau, P.
Date: 07/01/2004
Volume: 15
Issue: 7
Abstract | Full
Text
Title: Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476
Given Weekly in Patients with Advanced Malignancies
Autohors: Plummer, Ruth; Ghielmini, Michele; Calvert, Paula; Voi, Maurizio;
Renard, Josette; Gallant, Gilles; Gupta, Elora; Calvert, Hilary; Sessa, Cristiana
Date: 09/01/2002
Volume: 8
Issue: 9
Abstract | Full
Text
Title: Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476
Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin
Every 21 Days
Autohors: Sun, Weijing; Stevenson, James P.; Gallagher, Maryann L.; Vaughn,
David; Hahn, Steven M.; Haller, Daniel G.; Cohen, Marvin; Kopit, Justin; Gallant,
Gilles; O'Dwyer, Peter J.
Date: 11/01/2003
Volume: 9
Issue: 14
Abstract | Full
Text
Title: Phase I and Pharmacological Study of Two Schedules of the Antifolate
Edatrexate in Combination with Cisplatin
Autohors: Laurie, Scott A.; Pfister, David G.; Kris, Mark G.; Tong, William
P.; Chronowski, Greg; Pisters, Katherine M. W.; Heelan, Robert T.; Sirotnak,
Francis M.
Date: 03/01/2001
Volume: 7
Issue: 3
Abstract | Full
Text
Title: Phase I clinical study of infusional 5-fluorouracil with oxaliplatin
and gemcitabine (FOG regimen) in patients with solid tumors
Autohors: Goel, S.; Bulgaru, A.; Hochster, H.; Wadler, S.; Zamboni, W.;
Egorin, M.; Ivy, P.; Leibes, L.; Muggia, F.; Lockwood, G.; Harvey, E.; Renshaw,
G.; Mani, S.
Date: 11/01/2003
Volume: 14
Issue: 11
Abstract | Full
Text
